X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://inhibrx.investorroom.com/2024-02-28-Inhibrx-Reports-Fourth-Quarter-and-Fiscal-Year-2023-Financial-Results
https://endpts.com/arecor-to-retain-inhibrx-royalties-in-wake-of-sanofi-acquisition/
https://www.prnewswire.com/news-releases/inhibrx-announces-sale-of-inbrx-101-to-sanofi-for-an-aggregate-value-of-up-to-2-2b-302041424.html
https://www.prnewswire.com/news-releases/inhibrx-reports-third-quarter-2023-financial-results-and-recent-corporate-highlights-301983694.html
https://www.prnewswire.com/news-releases/inhibrx-announces-preliminary-data-from-the-phase-1-trial-of-inbrx-109-for-the-treatment-of-ewing-sarcoma-301975697.html
https://www.prnewswire.com/news-releases/inhibrx-announces-participation-in-upcoming-scientific-conferences-301961115.html
https://www.prnewswire.com/news-releases/inhibrx-announces-200-million-private-placement-financing-301912081.html
https://www.prnewswire.com/news-releases/inhibrx-granted-fast-track-designation-for-inbrx-101-for-the-treatment-of-alpha-1-antitrypsin-deficiency-301836311.html
https://www.prnewswire.com/news-releases/inhibrx-reports-first-quarter-2023-financial-results-and-recent-corporate-highlights-301817612.html
https://www.prnewswire.com/news-releases/inhibrx-initiates-a-registration-enabling-trial-of-inbrx-101-in-aatd-and-announces-lift-of-partial-clinical-hold-on-inbrx-109-dr5-agonist-trials-301807980.html
Market Place
Share 
